Long Term Efficacy, Safety and Immunogenicity of Enerceptan in Rheumatoid Arthritis ( GEMENE002 )

Clinical trial NCT03403140 · UNKNOWN

Trial details

NCT number: NCT03403140
Sponsor: Gema Biotech S.A.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2016-10-06
Primary completion: 2018-09-30
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.